Search results
Showing 6251 to 6300 of 8914 results
Recommendation ID TA293/2 Question NICE recommends research generating and analysing observational data including, but not limited to,
Recommendation ID TA161/2 Question [NICE] recommends research into the long-term effects of bisphosphonates on bone quality, given the
Recommendation ID TA254/2 Question NICE recommends that a new model for multiple sclerosis is developed, ideally based on UK patient cohorts
Recommendation ID TA274/1 Question NICE recommends that further research directly comparing the clinical and cost effectiveness of ranibizumab
Recommendation ID TA293/1 Question NICE recommends that research should be carried out to directly compare eltrombopag with non-thrombopoietin
Recommendation ID TA254/1 Question NICE recommends the development of patient registries for multiple sclerosis to capture long-term treatment-related
Recommendation ID HST1/1 Question NICE recommends the use of eculizumab for atypical haemolytic uraemic syndrome (aHUS) only if all the
Recommendation ID TA316/1 Question NICE supports the manufacturer's ongoing commitment to collect data on the effectiveness of enzalutamide
Recommendation ID NG31/3 Question Noisy respiratory secretions:- In people considered to be in the last few hours and days of life, are
Recommendation ID NG49/3 Question Non-invasive tests for diagnosing NAFLD and advanced liver fibrosis in children and young people:- Which
Recommendation ID PH47/4 Question Recommendation 4 Weight management programmes. Who should take action? Research councils, commissioners
Recommendation ID NG24/1 Question Red blood cell transfusion thresholds for patients with chronic cardiovascular disease:- What is the
Recommendation ID NG15/1 Question Reducing antimicrobial resistance:- What interventions, systems and processes are effective and cost
Recommendation ID NG48/5 Question Reducing demands on health and social care services:- Do preventive oral health interventions in residential
Recommendation ID NG76/6 Question Reducing social isolation and associated child abuse and neglect:- What is the impact of social isolation
Recommendation ID CG151/4 Question Reducing the risk of complications of anticancer treatment in children and young people, and in adults
Recommendation ID PH47/3 Question Recommendation 3 Barriers and facilitators. Who should take action? Research councils, commissioners
Recommendation ID NG228/01 Question Timing of CT head scans: What is the relative accuracy of CT head scans at different time intervals
Recommendation ID SG1/1 Question What is the relationship between the following factors and outcomes related to nursing care, patient safety
Recommendation ID PH55/6 Question What is the relative effectiveness and cost effectiveness of the different components of multi-component
Recommendation ID IPG724/01 Question Evidence is adequate on the short-term safety and efficacy of personalised external aortic root support
Recommendation ID CG184/5 Question What specialist investigations should be conducted to exclude a diagnosis of functional dyspepsia in
Recommendation ID CG184/4 Question What specialist management is effective for people whose symptoms do not respond to PPIs despite optimum
Recommendation ID TA235/1 Question Further studies on the clinical effectiveness of mifamurtide when combined with the chemotherapy typical
Recommendation ID NG63/3 Question High-risk groups:- What interventions to prevent infection and reduce antimicrobial resistance are effective
Recommendation ID NG63/2 Question Behavioural strategies and programmes:- What is the feasibility and effectiveness of specific behavioural
Recommendation ID NG63/1 Question Cost effectiveness:- What is the cost effectiveness of interventions to prevent infection and promote
Recommendation ID NG63/5 Question Older people in day and residential care:- How effective are interventions in day and residential care
Recommendation ID NG63/4 Question Workplace:- How effective are interventions in the workplace that aim to prevent infection and reduce
Recommendation ID NG156/1 Question What are the most effective and cost-effective frequencies for monitoring people with unruptured abdominal
Recommendation ID NG129/1 Question What are the benefits, risk and cost effectiveness of enteral nutrition in maintaining remission in
Recommendation ID CG152/3 Question 5-aminosalicylate (5-ASA) treatment:- Following successful medical induction of remission of Crohn's
Recommendation ID NG36/4 Question Enteral nutrition support:- What specific clinical and non-clinical factors allow risk stratification
Recommendation ID NG36/3 Question Unknown primary of presumed upper aerodigestive tract origin:- In people with CUADT of unknown primary
Recommendation ID NG36/1 Question Systemic imaging – who and why?:- What factors determine the risk of a person presenting with CUADT having
Recommendation ID NG36/5 Question Follow-up:- What is the optimal method, frequency and duration of follow-up for people who are disease-free
Recommendation ID NG36/2 Question HPV testing:- What is the comparative effectiveness of single-step laboratory diagnostic tests to identify
Recommendation ID IPG778 Question Further research should be in the form of randomised controlled trials or registries. It should report:
Recommendation ID NG146/2 Question What interventions are effective and cost effective in supporting return to work after recurrent short-term
Recommendation ID NG146/3 Question For people with common mental health conditions, what interventions are effective and cost effective
Recommendation ID NG146/1 Question What interventions are effective and cost effective in supporting return to work, in all workplaces
Recommendation ID CG139/3 Question Intermittent urinary catheters: catheter selection:- For patients performing intermittent self-catheterisation
Recommendation ID HST8/2 Question The committee also noted that the additional evidence exploring the relationship between radiological
Recommendation ID NG80/8 Question Additional maintenance therapy for asthma uncontrolled on a moderate dose of ICS plus LABA with or without
Recommendation ID CG128/3 Question Additional assessments:- Do additional assessments (for IQ, language ability and motor ability) improve
Recommendation ID NG10/3 Question Advance statements and decisions:- What forms of management of violence and aggression do service users
Recommendation ID NG161/1 Question Risk of systemic anticancer treatment in people with cancer and COVID-19: Are patients with cancer and
Recommendation ID NG162/1 Question Risk of radiotherapy in people with cancer and COVID-19: Are patients with cancer and COVID-19 who are
Recommendation ID NG103/4 Question Opt-out strategies for front-line health and social care staff:- Are opt-out strategies effective and
Recommendation ID NG88/5 Question Second-generation endometrial ablation for HMB associated with myometrial pathology:- Are outcomes after